Capital Management Associates (New York)’s Edwards Lifesciences EW Stock Holding History

Capital Management Associates (New York)’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-11,400	Closed	-$790K	–	84
2023 Q3	$790K	Hold	11,400	–	–	1.16%	31
2023 Q2	$1.08M	Hold	11,400	–	–	1.58%	18
2023 Q1	$943K	Hold	11,400	–	–	1.43%	29
2022 Q4	$851K	Hold	11,400	–	–	1.26%	36
2022 Q3	$942K	Hold	11,400	–	–	1.37%	29
2022 Q2	$1.08M	Hold	11,400	–	–	1.6%	23
2022 Q1	$1.34M	Hold	11,400	–	–	1.44%	25
2021 Q4	$1.48M	Hold	11,400	–	–	1.45%	20
2021 Q3	$1.29M	Hold	11,400	–	–	1.27%	33
2021 Q2	$1.18M	Hold	11,400	–	–	1.13%	40
2021 Q1	$953K	Hold	11,400	–	–	0.98%	47
2020 Q4	$1.04M	Hold	11,400	–	–	1.14%	39
2020 Q3	$910K	Hold	11,400	–	–	1.2%	34
2020 Q2	$788K	Hold	11,400	–	–	1.11%	38
2020 Q1	$717K	Hold	11,400	–	–	1.3%	31
2019 Q4	$887K	Hold	11,400	–	–	1.22%	31
2019 Q3	$836K	Hold	11,400	–	–	1.29%	25
2019 Q2	$702K	Hold	11,400	–	–	1.14%	30
2019 Q1	$727K	Hold	11,400	–	–	1.13%	27
2018 Q4	$582K	Hold	11,400	–	–	1.1%	35
2018 Q3	$662K	Buy	11,400 +2,835	+33%	+$139K	0.82%	46
2018 Q2	$416K	Buy	+8,565	New	+$400K	0.52%	94

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Management Associates (New York)'s EW Position: Q4 2023 in Review

Capital Management Associates (New York) sold out of Edwards Lifesciences (EW) in Q4 2023, closing a stake of 11,400 shares — an estimated $790K sold.

Capital Management Associates (New York) first reported a position in EW in Q2 2018 and held it in 22 quarters. The position peaked at $1.48M in Q4 2021. 1,245 funds tracked by Wall St. Rank hold EW as of Q4 2023.

Capital Management Associates (New York) reported no remaining Edwards Lifesciences position as of Q4 2023 after selling out during the quarter.
Capital Management Associates (New York) sold 11,400 Edwards Lifesciences shares in Q4 2023, an estimated $790K.
Capital Management Associates (New York) first reported a position in Edwards Lifesciences in Q2 2018 and held it in 22 quarters.
Capital Management Associates (New York)'s Edwards Lifesciences position peaked at $1.48M in Q4 2021.
1,245 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2023.

Based on Capital Management Associates (New York)'s 13F filing for Q4 2023, filed 9 Feb 2024.